These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 3798928)

  • 21. European and American recommendations for coronary heart disease prevention.
    Wood D
    Eur Heart J; 1998 Feb; 19 Suppl A():A12-9. PubMed ID: 9519337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serum cholesterol and diabetes mellitus: main independent risk factors of ischemic heart disease mortality in Mexico].
    Escobedo de la Peña J; Escamilla Cejudo JA; Santos-Burgoa C
    Arch Inst Cardiol Mex; 1994; 64(2):189-95. PubMed ID: 8074590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesterol and coronary heart disease. The importance of patient-specific attributable risk.
    Malenka DJ; Baron JA
    Arch Intern Med; 1988 Oct; 148(10):2247-52. PubMed ID: 3178382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cerivastatin on serum cholesterol levels in patients with type 2 diabetes mellitus.
    De Luis DA; Romero E; Aller R; Izaola O
    Clin Nutr; 2000 Oct; 19(5):367-70. PubMed ID: 11031077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diet and coronary heart disease.
    Stamler J
    Biometrics; 1982 Mar; 38 Suppl():95-118. PubMed ID: 7046825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differences between management guidelines and global health strategies for arterial hypertension with metabolic disorders in France in 1999. Ohara study].
    Mallion JM; Kahn JC; Poncelet P; Pannier B; Vaïsse B; Koch C; Phan TM; Pithois-Merli I
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):834-8. PubMed ID: 11575213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke prevention: management of modifiable vascular risk factors.
    Leys D; Deplanque D; Mounier-Vehier C; Mackowiak-Cordoliani MA; Lucas C; Bordet R
    J Neurol; 2002 May; 249(5):507-17. PubMed ID: 12021938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Coronary artery disease in diabetic patients].
    Tanaka T; Yazu T; Takagi E; Watanabe M; Miyahara M; Sekoguchi K; Tanaka R; Shiozaki A; Fukui A; Futagami Y
    Kokyu To Junkan; 1992 Mar; 40(3):271-4. PubMed ID: 1579750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidence of coronary disease and other metabolic diseases in 80 gout patients].
    Pianzola EL; Ulloa Lugo S; Robles Gil J
    Arch Inst Cardiol Mex; 1979; 49(1):25-33. PubMed ID: 434957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of myocardial infarct?].
    Turini GA; Brunner HR
    Schweiz Med Wochenschr; 1978 Apr; 108(15):545-50. PubMed ID: 644271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ecg alterations and cardiac risk factors in diabetics metabolism. A prevalence study in psychiatric in-patients (author's transl)].
    Schwalb H; Fischer J
    Z Kardiol; 1979 Feb; 68(2):116-22. PubMed ID: 311558
    [No Abstract]   [Full Text] [Related]  

  • 32. Diet, serum cholesterol and the prevention of coronary heart disease in New Zealand.
    Beaglehole R; Jackson R; Stewart A
    N Z Med J; 1988 Jun; 101(848):415-8. PubMed ID: 3393329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The biological bases for prevention].
    Paoletti R; Poli A
    G Ital Cardiol; 1989 Sep; 19(9):763-9; discussion 778-86. PubMed ID: 2612822
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of coronary heart disease in Pakistani patients suffering from maturity onset diabetes mellitus.
    Haider Z; Obaidullah S; Ud Din F; Zubair M; Saleem M
    J Trop Med Hyg; 1978 Jun; 81(6):98-102. PubMed ID: 660715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Coronary heart disease and diabetes mellitus. Who is at risk? The significance of cholesterol and blood sugar determinations (author's transl)].
    Stähelin HB
    Schweiz Rundsch Med Prax; 1977 Dec; 66(52):1669-73. PubMed ID: 600903
    [No Abstract]   [Full Text] [Related]  

  • 36. [When should hypercholesterolemia patients be diagnosed and treated?].
    Jacotot B
    Rev Prat; 1989 Apr; 39(12):1046-8. PubMed ID: 2740768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.
    Assmann G; Schulte H
    Am Heart J; 1988 Dec; 116(6 Pt 2):1713-24. PubMed ID: 3202078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of blood sugar, therapy and blood pressure on lipoprotein profiles of diabetics in Trinidad & Tobago. Possible association with ischaemic heart disease.
    Ragoobirsingh D; Davidson JB
    West Indian Med J; 1989 Jun; 38(2):94-8. PubMed ID: 2763537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lipid metabolism disorder: detection and treatment. 5: Treatment of hyperlipidemia in manifest coronary heart disease, diabetes mellitus and hypertension. National cholesterol initiative].
    Assmann G
    Fortschr Med; 1991 Jun; 109(17):361-3. PubMed ID: 1885117
    [No Abstract]   [Full Text] [Related]  

  • 40. Coronary heart disease in hypertensives: a need to reduce cholesterol.
    Heyden S; Schneider KA; Fodor GJ
    Int J Epidemiol; 1988 Dec; 17(4):784-8. PubMed ID: 3066769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.